Evidence map›Paper›PMID 36253028›Full record

ReviewAdvances in chronic kidney disease2022

Artificial Intelligence in Acute Kidney Injury Prediction.

Tushar Bajaj, Jay L Koyner

Abstract readReview
In one paragraph

Review in Advances in chronic kidney disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. New approaches to acute kidney injury.Clinical kidney journal · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tushar BajajSection of Nephrology, Department of Medicine University of Chicago, Chicago, IL, USA.
Jay L KoynerSection of Nephrology, Department of Medicine University of Chicago, Chicago, IL, USA. Electronic address: jkoyner@uchicago.edu.

Funding

Using Machine Learning for Early Recognition and Personalized Treatment of Acute Kidney InjuryR01DK126933 · NIDDK · UNIVERSITY OF CHICAGO · PI CHURPEK, MATTHEW MICHAEL, KOYNER, JAY L · 2021 to 2025
$3.4M
NIDDK NIH HHS R01 DK126933
6 · The paper itself

Abstract

The use of artificial intelligence (AI) in nephrology and its associated clinical research is growing. Recent years have seen increased interest in utilizing AI to predict the development of hospital-based acute kidney injury (AKI). Several AI techniques have been employed to improve the ability to detect AKI across a variety of hospitalized settings. This review discusses the evolutions of AKI risk prediction discussing the static risk assessment models of yesteryear as well as the more recent trend toward AI and advanced learning techniques. We discuss the relative improvement in AKI detection as well as the relative dearth of data around the clinical implementation and patient outcomes using these models. The use of AI for AKI detection and clinical care is in its infancy, and this review describes how we arrived at our current position and hints at the promise of the future.

Indexed as

Acute Kidney InjuryNephrologyArtificial IntelligenceHospitalizationHumansRisk AssessmentAcute kidney injuryArtificial intelligenceMachine learningRenal replacement therapyRisk prediction

Identifiers

PMID36253028
PMCPMC10259199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.